Pharmaceutical major AstraZeneca has opened a $40 million research facility in Bangalore on Monday.
The centre would primarily focus on finding new treatments for tuberculosis (TB), a disease which is diagnosed in about two million people every year in India and over eight million people worldwide. The company has set an
